| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008442A1 Novel acyl peptides with leishmanicidal activity |
| 01/30/2003 | WO2003008441A2 Moringa seed proteins |
| 01/30/2003 | WO2003008440A2 Nucleic acid molecules encoding proteins essential for plant growth |
| 01/30/2003 | WO2003008438A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 01/30/2003 | WO2003008437A2 Protein and nucleic acid expression systems |
| 01/30/2003 | WO2003008435A2 Gfp fusion proteins and their use |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2003007890A2 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007886A2 Plant ion channels and methods |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
| 01/30/2003 | WO2003007699A2 Transcription factors of cereals |
| 01/30/2003 | WO2002090986A9 Colon cancer antigen panel |
| 01/30/2003 | WO2002089817A3 Anti-virus agent |
| 01/30/2003 | WO2002086130A3 Production of genetically modified plants with puroindolines |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002070538A9 Narc8 programmed cell-death-associated molecules and uses thereof |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002060945A3 Human ion channel protein and polynucleotides encoding the same |
| 01/30/2003 | WO2002060917A3 Method to treat hemophilia |
| 01/30/2003 | WO2002059337A9 Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 01/30/2003 | WO2002059332A3 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 01/30/2003 | WO2002055101A3 Storage stable powder compositions of interleukin-4 receptor |
| 01/30/2003 | WO2002051435A3 New therapeutic uses of smr1 peptides |
| 01/30/2003 | WO2002048382A3 Method for the production of a heterologous protein by a fungus |
| 01/30/2003 | WO2002048180A3 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 01/30/2003 | WO2002047715A3 Compositions of peptide crystals |
| 01/30/2003 | WO2002044337A3 Wooden leg gene, promoter and uses thereof |
| 01/30/2003 | WO2002036769A3 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/30/2003 | WO2002036154A3 Procollagen (iii) propeptides and related substances for treating fibrotic diseases |
| 01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 01/30/2003 | WO2002034772A3 Novel compounds |
| 01/30/2003 | WO2002033115A3 Claspin proteins and methods of use thereof |
| 01/30/2003 | WO2002031150A3 Human ion channel protein and polynucleotides encoding the same |
| 01/30/2003 | WO2002031143A3 Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| 01/30/2003 | WO2002030321A3 Bird diagnostics and treatments |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002026766A3 Haplotypes of the sstr4 gene |
| 01/30/2003 | WO2002024894A3 Human protease inhibitor proteins and polynucleotides encod ing the same |
| 01/30/2003 | WO2002024890A3 Rice mlh1 ortholog and uses thereof |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/30/2003 | WO2002016603A3 23228, a novel human tetraspanin family member and uses thereof |
| 01/30/2003 | WO2002014501A3 Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer |
| 01/30/2003 | WO2002014356A3 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 01/30/2003 | WO2002012553A3 Method for detecting mutations in nucleotide sequences |
| 01/30/2003 | WO2002012285A3 The tumor suppressor car-1 |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002010362A3 Methods of controlling gene expression and gene silencing |
| 01/30/2003 | WO2002008277A3 Nucleic acids, vectors, host cells, polypeptides, and uses thereof |
| 01/30/2003 | WO2002007773A3 Multi-component biological transport systems |
| 01/30/2003 | WO2002006322A3 Polycomb genes mez1 and mez2 from maize |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2002004526A3 Production of a cellulose-like polysaccharide by peudomonas fluorescens |
| 01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/30/2003 | WO2002002809A3 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2002000719A3 Human and mouse g-protein couipled receptors |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | WO2001094416A3 Human proteins and nucleic acids encoding same |
| 01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001081576A3 Novel g protein-coupled receptor con-218 |
| 01/30/2003 | WO2001079293A3 Human cadherin molecules and uses therefor |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001077172A3 Non-endogenous, constitutively activated known g protein-coupled receptors |
| 01/30/2003 | WO2001077161A3 Gtp binding stress-related proteins and methods of use in plants |
| 01/30/2003 | WO2001068853A3 Immunogenic ovarian cancer genes |
| 01/30/2003 | WO2001068835A3 Method for modifying a nucleic acid |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | WO2001025273A9 Compositions and methods for wt1 specific immunotherapy |
| 01/30/2003 | US20030024013 Gene controlling fruit size and cell division in plants |
| 01/30/2003 | US20030024008 Amplification of crop yield; obtain nucleotide sequences, generate vector, infect cells, recover transform cells, propagate and monitor seed generation |
| 01/30/2003 | US20030024007 Plant Myb transcription factor homologs |
| 01/30/2003 | US20030024006 Gene switches |
| 01/30/2003 | US20030024004 ZmAxig1 polynucleotides and methods of use |
| 01/30/2003 | US20030024003 Moss genes from Physcomitrella patens encoding proteins involved in the regulation of cell division, growth and biomass formation in plants |
| 01/30/2003 | US20030024001 Animal models for use in the treatment of psychological and nervous system disorders |
| 01/30/2003 | US20030024000 Animal models for use in the treatment of injuries and psoriasis |
| 01/30/2003 | US20030023999 Transgenic mice containing GNB1 gene disruptions |
| 01/30/2003 | US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease |
| 01/30/2003 | US20030023996 Nucleotide sequences coding protein for use in the diagnosis and treatment of prostate cancer |
| 01/30/2003 | US20030023995 Animal model for use in the diagnosis and treatment of cell proliferative and nervous system disorders |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023992 Novel G protein-coupled receptors |
| 01/30/2003 | US20030023991 Amplification or reduction of hair follicle, tooth or sweat gland development; obtain tissue, incubate with modulator, monitor, tissue development |
| 01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | US20030023075 Novel sequences of E. coli O157 |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023073 Growth differentiation factor-15 |
| 01/30/2003 | US20030023072 DNA encoding orphan SNORF9 receptor |
| 01/30/2003 | US20030023071 DNA encoding proteins that inhibit Hsp70 function |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023069 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/30/2003 | US20030023068 For diagnosis and therapy |